NasdaqCM - Delayed Quote USD
Kiora Pharmaceuticals, Inc. (KPRX)
3.2500
-0.0200
(-0.61%)
At close: May 9 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.76 | -0.74 | -2.99 | 0 |
| Low Estimate | -0.76 | -0.74 | -2.99 | 0 |
| High Estimate | -0.76 | -0.74 | -2.99 | 0 |
| Year Ago EPS | -0.53 | -0.81 | 0.87 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | 750k | 750k | 3M | 1.5M |
| Low Estimate | -- | -- | -- | 1.5M |
| High Estimate | 1.5M | 1.5M | 6M | 1.5M |
| Year Ago Sales | 20k | -- | 16.02M | 3M |
| Sales Growth (year/est) | 3,650.00% | 0.00% | -81.27% | -50.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.88 | -0.81 | -0.74 | -0.77 |
| EPS Actual | -0.53 | -0.81 | -1.21 | -0.52 |
| Difference | 0.35 | 0 | -0.47 | 0.25 |
| Surprise % | 39.77% | 0.61% | -63.19% | 32.47% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.76 | -0.74 | -2.99 | 0 |
| 7 Days Ago | -0.68 | -0.7 | -2.76 | 0 |
| 30 Days Ago | -0.68 | -0.7 | -2.76 | 0 |
| 60 Days Ago | -0.6 | -0.56 | -2.39 | 0 |
| 90 Days Ago | -0.6 | -0.56 | -2.39 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KPRX | -43.40% | 8.64% | -442.74% | -- |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/12/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/22/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 7/23/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/20/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/27/2024 |
Related Tickers
PALI Palisade Bio, Inc.
0.7546
-1.35%
REVB Revelation Biosciences, Inc.
3.1781
+2.85%
QNRX Quoin Pharmaceuticals, Ltd.
6.19
-3.43%
XBIO Xenetic Biosciences, Inc.
3.0600
-2.86%
VRAX Virax Biolabs Group Limited
1.0500
-0.94%
PXMD PaxMedica, Inc.
0.0001
0.00%
BDRX Biodexa Pharmaceuticals Plc
1.4100
+0.71%
GBIO Generation Bio Co.
0.3600
+0.06%
VTVT vTv Therapeutics Inc.
20.80
-2.12%
YMAB Y-mAbs Therapeutics, Inc.
3.8900
-3.71%